Clinical Trial Detail

NCT ID NCT00610948
Title Everolimus, Fluorouracil, Leucovorin, Panitumumab, and Oxaliplatin in Treating Patients With Solid Tumors That Did Not Respond to Treatment
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements no
Sponsors UNC Lineberger Comprehensive Cancer Center
Indications

Advanced Solid Tumor

Therapies

Everolimus

Panitumumab

Age Groups: adult

No variant requirements are available.